Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Association Between Hematological Parameters and Iron Metabolism Response After Marathon Race and ACTN3 Genotype.

Sierra APR, Oliveira RA, Silva ED, Lima GHO, Benetti MP, Kiss MAP, Sierra CA, Ghorayeb N, Seto JT, Pesquero JB, Cury-Boaventura MF.

Front Physiol. 2019 Jun 11;10:697. doi: 10.3389/fphys.2019.00697. eCollection 2019.

2.

Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathy.

Blondelle J, Tallapaka K, Seto JT, Ghassemian M, Clark M, Laitila JM, Bournazos A, Singer JD, Lange S.

JCI Insight. 2019 Apr 16;5. pii: 125665. doi: 10.1172/jci.insight.125665.

3.

Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease.

Houweling PJ, Papadimitriou ID, Seto JT, Pérez LM, Coso JD, North KN, Lucia A, Eynon N.

Hum Mutat. 2018 Dec;39(12):1774-1787. doi: 10.1002/humu.23663. Epub 2018 Nov 8. Review.

PMID:
30281865
4.

The Effect of ACTN3 Gene Doping on Skeletal Muscle Performance.

Garton FC, Houweling PJ, Vukcevic D, Meehan LR, Lee FXZ, Lek M, Roeszler KN, Hogarth MW, Tiong CF, Zannino D, Yang N, Leslie S, Gregorevic P, Head SI, Seto JT, North KN.

Am J Hum Genet. 2018 May 3;102(5):845-857. doi: 10.1016/j.ajhg.2018.03.009. Epub 2018 Apr 26.

5.

Exploring the relationship between α-actinin-3 deficiency and obesity in mice and humans.

Houweling PJ, Berman YD, Turner N, Quinlan KGR, Seto JT, Yang N, Lek M, Macarthur DG, Cooney G, North KN.

Int J Obes (Lond). 2017 Jul;41(7):1154-1157. doi: 10.1038/ijo.2017.72. Epub 2017 Mar 15.

6.

Analysis of the ACTN3 heterozygous genotype suggests that α-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion.

Hogarth MW, Garton FC, Houweling PJ, Tukiainen T, Lek M, Macarthur DG, Seto JT, Quinlan KG, Yang N, Head SI, North KN.

Hum Mol Genet. 2016 Mar 1;25(5):866-77. doi: 10.1093/hmg/ddv613. Epub 2015 Dec 17.

7.

Progress and prospects of gene therapy clinical trials for the muscular dystrophies.

Bengtsson NE, Seto JT, Hall JK, Chamberlain JS, Odom GL.

Hum Mol Genet. 2016 Apr 15;25(R1):R9-17. doi: 10.1093/hmg/ddv420. Epub 2015 Oct 8. Review.

8.

Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.

Seto JT, Bengtsson NE, Chamberlain JS.

Curr Pediatr Rep. 2014 Jun 1;2(2):102-112.

9.

α-Actinin-3 deficiency alters muscle adaptation in response to denervation and immobilization.

Garton FC, Seto JT, Quinlan KG, Yang N, Houweling PJ, North KN.

Hum Mol Genet. 2014 Apr 1;23(7):1879-93. doi: 10.1093/hmg/ddt580. Epub 2013 Nov 13.

PMID:
24234654
10.

NF1 is a critical regulator of muscle development and metabolism.

Sullivan K, El-Hoss J, Quinlan KG, Deo N, Garton F, Seto JT, Gdalevitch M, Turner N, Cooney GJ, Kolanczyk M, North KN, Little DG, Schindeler A.

Hum Mol Genet. 2014 Mar 1;23(5):1250-9. doi: 10.1093/hmg/ddt515. Epub 2013 Oct 24.

11.

ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling.

Seto JT, Quinlan KG, Lek M, Zheng XF, Garton F, MacArthur DG, Hogarth MW, Houweling PJ, Gregorevic P, Turner N, Cooney GJ, Yang N, North KN.

J Clin Invest. 2013 Oct;123(10):4255-63. doi: 10.1172/JCI67691. Epub 2013 Sep 16.

12.

Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Seto JT, Ramos JN, Muir L, Chamberlain JS, Odom GL.

Curr Gene Ther. 2012 Jun;12(3):139-51. Review.

13.

α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse.

Yang N, Schindeler A, McDonald MM, Seto JT, Houweling PJ, Lek M, Hogarth M, Morse AR, Raftery JM, Balasuriya D, MacArthur DG, Berman Y, Quinlan KG, Eisman JA, Nguyen TV, Center JR, Prince RL, Wilson SG, Zhu K, Little DG, North KN.

Bone. 2011 Oct;49(4):790-8. doi: 10.1016/j.bone.2011.07.009. Epub 2011 Jul 19.

PMID:
21784188
14.

Deficiency of α-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling.

Seto JT, Lek M, Quinlan KG, Houweling PJ, Zheng XF, Garton F, MacArthur DG, Raftery JM, Garvey SM, Hauser MA, Yang N, Head SI, North KN.

Hum Mol Genet. 2011 Aug 1;20(15):2914-27. doi: 10.1093/hmg/ddr196. Epub 2011 May 2.

PMID:
21536590
15.

Therapeutic approaches to muscular dystrophy.

Goyenvalle A, Seto JT, Davies KE, Chamberlain J.

Hum Mol Genet. 2011 Apr 15;20(R1):R69-78. doi: 10.1093/hmg/ddr105. Epub 2011 Mar 24. Review.

16.

The effect of α-actinin-3 deficiency on muscle aging.

Seto JT, Chan S, Turner N, MacArthur DG, Raftery JM, Berman YD, Quinlan KG, Cooney GJ, Head S, Yang N, North KN.

Exp Gerontol. 2011 Apr;46(4):292-302. doi: 10.1016/j.exger.2010.11.006. Epub 2010 Nov 26.

PMID:
21112313
17.

Properties of extensor digitorum longus muscle and skinned fibers from adult and aged male and female Actn3 knockout mice.

Chan S, Seto JT, Houweling PJ, Yang N, North KN, Head SI.

Muscle Nerve. 2011 Jan;43(1):37-48. doi: 10.1002/mus.21778. Epub 2010 Sep 30.

PMID:
20886650
18.

Validation of an automated computational method for skeletal muscle fibre morphometry analysis.

Garton F, Seto JT, North KN, Yang N.

Neuromuscul Disord. 2010 Aug;20(8):540-7. doi: 10.1016/j.nmd.2010.06.012. Epub 2010 Jul 17.

PMID:
20638845
19.

Alpha-actinin-3 deficiency results in reduced glycogen phosphorylase activity and altered calcium handling in skeletal muscle.

Quinlan KG, Seto JT, Turner N, Vandebrouck A, Floetenmeyer M, Macarthur DG, Raftery JM, Lek M, Yang N, Parton RG, Cooney GJ, North KN.

Hum Mol Genet. 2010 Apr 1;19(7):1335-46. doi: 10.1093/hmg/ddq010. Epub 2010 Jan 20.

PMID:
20089531
20.

Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy.

Compton AG, Albrecht DE, Seto JT, Cooper ST, Ilkovski B, Jones KJ, Challis D, Mowat D, Ranscht B, Bahlo M, Froehner SC, North KN.

Am J Hum Genet. 2008 Dec;83(6):714-24. doi: 10.1016/j.ajhg.2008.10.022. Epub 2008 Nov 20.

21.

A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse.

Chan S, Seto JT, MacArthur DG, Yang N, North KN, Head SI.

Am J Physiol Cell Physiol. 2008 Oct;295(4):C897-904. doi: 10.1152/ajpcell.00179.2008. Epub 2008 Jul 23.

22.

An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance.

MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N, Nicholson MD, Kee AJ, Hardeman EC, Gunning PW, Cooney GJ, Head SI, Yang N, North KN.

Hum Mol Genet. 2008 Apr 15;17(8):1076-86. doi: 10.1093/hmg/ddm380. Epub 2008 Jan 4.

PMID:
18178581
23.

Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.

Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V, Compton AG, Cairns AG, Corbett A, MacArthur DG, Yang N, Reardon K, North KN.

Neuromuscul Disord. 2008 Jan;18(1):34-44. Epub 2007 Sep 25.

PMID:
17897828
24.

Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans.

MacArthur DG, Seto JT, Raftery JM, Quinlan KG, Huttley GA, Hook JW, Lemckert FA, Kee AJ, Edwards MR, Berman Y, Hardeman EC, Gunning PW, Easteal S, Yang N, North KN.

Nat Genet. 2007 Oct;39(10):1261-5. Epub 2007 Sep 9.

PMID:
17828264
25.

Determinants of organ tropism of sendai virus.

Tashiro M, McQueen NL, Seto JT.

Front Biosci. 1999 Oct 1;4:D642-5. Review.

PMID:
10502551
26.

Determinants of pantropism of the F1-R mutant of Sendai virus: specific mutations involved are in the F and M genes.

Okada H, Seto JT, McQueen NL, Klenk HD, Rott R, Tashiro M.

Arch Virol. 1998;143(12):2343-52.

PMID:
9930191
27.

Determinants of organ tropism of Sendai virus.

Tashiro M, Seto JT.

Front Biosci. 1997 Dec 1;2:d588-91. Review.

PMID:
9369500
28.

Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus.

Tashiro M, McQueen NL, Seto JT, Klenk HD, Rott R.

J Virol. 1996 Sep;70(9):5990-7.

29.
30.

Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H.

J Virol. 1992 Dec;66(12):7211-6.

31.

Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice.

Tashiro M, Seto JT, Choosakul S, Hegemann H, Klenk HD, Rott R.

J Gen Virol. 1992 Jun;73 ( Pt 6):1575-9.

PMID:
1339465
32.

Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice.

Tashiro M, Seto JT, Choosakul S, Yamakawa M, Klenk HD, Rott R.

Virology. 1992 Apr;187(2):413-22.

PMID:
1312267
33.

Significance of basolateral domain of polarized MDCK cells for Sendai virus-induced cell fusion.

Tashiro M, Yamakawa M, Tobita K, Klenk HD, Seto JT, Rott R.

Arch Virol. 1992;125(1-4):129-39.

PMID:
1322649
34.

Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.

Tashiro M, James I, Karri S, Wahn K, Tobita K, Klenk HD, Rott R, Seto JT.

Virology. 1991 Sep;184(1):227-34.

PMID:
1651590
35.

Molecular biology of the pathogenesis of Sendai viruses.

Seto JT, Tashiro M.

Behring Inst Mitt. 1991 Jul;(89):54-8. Review.

PMID:
1656934
36.

Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells.

Tashiro M, Yamakawa M, Tobita K, Seto JT, Klenk HD, Rott R.

J Virol. 1990 Oct;64(10):4672-7.

37.
38.

Nucleotide sequence analyses of the genes encoding the HN, M, NP, P, and L proteins of two host range mutants of Sendai virus.

Middleton Y, Tashiro M, Thai T, Oh J, Seymour J, Pritzer E, Klenk HD, Rott R, Seto JT.

Virology. 1990 Jun;176(2):656-7.

PMID:
2161155
39.
40.

Characterization of a pantropic variant of Sendai virus derived from a host range mutant.

Tashiro M, Pritzer E, Khoshnan MA, Yamakawa M, Kuroda K, Klenk HD, Rott R, Seto JT.

Virology. 1988 Aug;165(2):577-83.

PMID:
2841801
41.

Persistent infections with Sendai virus and Newcastle disease viruses.

Lawton P, Karimi Z, Mancinelli L, Seto JT.

Arch Virol. 1986;89(1-4):225-33.

PMID:
3013129
42.

Scanning electron microscope examination of epithelial cells infected with enveloped viruses.

Apelian Z, Hong LC, Seto JT.

J Virol Methods. 1984 Feb;8(1-2):147-54.

PMID:
6323507
45.
46.

Glycoproteins of representative paramyxoviruses: isolation and antigenic analysis using a zwitterionic surfactant.

Dyke SF, Williams W, Seto JT.

J Med Virol. 1978;2(2):143-52. No abstract available.

PMID:
209128
47.

Glycoproteins of Sendai virus: purification and antigenic analysis.

Urata DM, Seto JT.

Intervirology. 1975-1976;6(2):108-14.

PMID:
58850
48.

Effect of specific antibodies on biological functions of the envelope components of Newcastle disease virus.

Seto JT, Becht H, Rott R.

Virology. 1974 Oct;61(2):354-60. No abstract available.

PMID:
4213724
49.

Isolation and purification of surface antigens from disrupted paramyxoviruses.

Seto JT, Becht H, Rott R.

Med Microbiol Immunol. 1973 Sep 26;159(1):1-12. No abstract available.

PMID:
4358741
50.

Electron microscope study of double-stranded ribonucleic acid of influenza virus infected cells.

Chang SS, Seto JT.

J Gen Virol. 1972 Oct;17(1):99-105. No abstract available.

PMID:
4673481

Supplemental Content

Support Center